Procalcitonin Versus C-Reactive Protein for Guiding Antibiotic Therapy in Sepsis: A Randomized Trial*
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We sought to evaluate whether procalcitonin was superior to C-reactive protein in guiding antibiotic therapy in intensive care patients with sepsis. DESIGN: Randomized open clinical trial. SETTING: Two university hospitals in Brazil. PATIENTS: Patients with severe sepsis or septic shock. INTERVENTIONS: Patients were randomized in two groups: the procalcitonin group and the C-reactive protein group. Antibiotic therapy was discontinued following a protocol based on serum levels of these markers, according to the allocation group. The procalcitonin group was considered superior if the duration of antibiotic therapy was at least 25% shorter than in the C-reactive protein group. For both groups, at least seven full-days of antibiotic therapy were ensured in patients with Sequential Organ Failure Assessment greater than 10 and/or bacteremia at inclusion, and patients with evident resolution of the infectious process had antibiotics stopped after 7 days, despite biomarkers levels. MEASUREMENTS AND MAIN RESULTS: Ninety-four patients were randomized: 49 patients to the procalcitonin group and 45 patients to the C-reactive protein group. The mean age was 59.8 (SD, 16.8) years. The median duration of antibiotic therapy for the first episode of infection was 7.0 (Q1-Q3, 6.0-8.5) days in the procalcitonin group and 6.0 (Q1-Q3, 5.0-7.0) days in the C-reactive protein group (p=0.13), with a hazard ratio of 1.206 (95% CI, 0.774-1.3; p=0.13). Overall, protocol overruling occurred in only 13 (13.8%) patients. Twenty-one patients died in each group (p=0.836). CONCLUSIONS: C-reactive protein was as useful as procalcitonin in reducing antibiotic use in a predominantly medical population of septic patients, causing no apparent harm.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109 · cited 1×
“The early and empirical initiation of antibiotic treatment is recommended for patients with suspected severe bacterial infection and is associated with lower mortality (2, 3).”
Background2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
Mermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638
Gupta, K., Hooton, T. M., Naber, K. G., Wullt, B., Colgan, R., Miller, L. G., Moran, G. J., Nicolle, L. E., Raz, R., Schaeffer, A. J., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq257 · Cited by 3,038
Serial Evaluation of the SOFA Score to Predict Outcome in Critically Ill Patients
Ferreira, F. L. (2001) · JAMA · doi:10.1001/jama.286.14.1754 · Cited by 2,862 · cited 1×
“The inclusion of the SOFA score sought to increase patient safety (39).”
BackgroundBouadma, L., Luyt, C.-E., Tubach, F., Cracco, C., Alvarez, A., Schwebel, C., Schortgen, F., Lasocki, S., Veber, B., Dehoux, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61879-1 · Cited by 1,183
SINGH, N., ROGERS, P., ATWOOD, C. W., WAGENER, M. M., & YU, V. L. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9909095 · Cited by 1,032
Schuetz, P., Christ-Crain, M., Thomann, R., Falconnier, C., Wolbers, M., Widmer, I., Neidert, S., Fricker, T., Blum, C., Schild, U., et al. (2009) · JAMA · doi:10.1001/jama.2009.1297 · Cited by 959
Cited by
Items 201–215 of 215
Lien, F., Lin, H.-S., Wu, Y.-T., & Chiueh, T.-S. (2022) · Figshare · doi:10.6084/m9.figshare.19450989
de Barros, G. M., Borges, I. N., Ravetti, C. G., Diniz, P. H., Ferreira, S. R., Mori, L. H. D., Castro, R., Okamura, G. H., Gatto, F. R., & Junior, V. A. N. (2024) · Figshare · doi:10.6084/m9.figshare.27019302
Borges, I. N., Carneiro, R. M., Bergo, R., Martins, L., Colosimo, E. A., Oliveira, C., Saturnino, S. F., de Andrade, M. V. M., Ravetti, C., & Junior, V. A. N. (2020) · Figshare · doi:10.6084/m9.figshare.12414764
Self-citationBorges, I. N., Carneiro, R. M., Bergo, R., Martins, L., Colosimo, E. A., Oliveira, C., Saturnino, S. F., de Andrade, M. V. M., Ravetti, C., & Junior, V. A. N. (2020) · Figshare · doi:10.6084/m9.figshare.12414737
Self-citationDias, R. F., de Paula, A. C. R. B., Hasparyk, Ú. G., de Oliveira Rabelo Bassalo Coutinho, M., Alderete, J. R. A., Kanjongo, J. C., Silva, R. A. M., Guimarães, N. S., Simões e Silva, A. C., & Junior, V. A. N. (2023) · Figshare · doi:10.6084/m9.figshare.22757262
Dias, R. F., de Paula, A. C. R. B., Hasparyk, Ú. G., de Oliveira Rabelo Bassalo Coutinho, M., Alderete, J. R. A., Kanjongo, J. C., Silva, R. A. M., Guimarães, N. S., Simões e Silva, A. C., & Junior, V. A. N. (2023) · Figshare · doi:10.6084/m9.figshare.22757259
Borges, I. N., Carneiro, R. M., Bergo, R., Martins, L., Colosimo, E. A., Oliveira, C., Saturnino, S. F., de Andrade, M. V. M., Ravetti, C., & Junior, V. A. N. (2020) · Figshare · doi:10.6084/m9.figshare.12414734
Self-citationde Rezende, V. M. L. R., Borges, I. N., Ravetti, C. G., DESOUZA, R. P., Vassallo, P. F., Caldas, A. C. D. P., Gatto, F. R., Okamura, G. H., Lacerda, R. L. D. B., XAVIER, T. U. S., et al. (2026) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2026.108708
Chandran, R., Swetha, M., Dharshini, S., Sheeba, S., Sri, S. S., Nivaethika, M. H., & Sujitha, K. (2026) · Journal for Research in Applied Sciences and Biotechnology · doi:10.55544/jrasb.5.2.2
Abdollahi, A., Nozheh, A., Yousefi, K. M., Salehi, M., & Modabber, Z. (2026) · Immunity Inflammation and Disease · doi:10.1002/iid3.70398
The Efficacy of Antibacterial Therapy in Patients with Sepsis and Septic Shock
Shapoval, С. D. (2026) · The Ukrainian Journal of Clinical Surgery · doi:10.26779/2786-832x.2026.3.72
Atalar, S., Yılmaz, G., Eroğlu, A., & Köksal, İ. (2026) · BMC Anesthesiology · doi:10.1186/s12871-026-04039-9
Rampershad, K. (2026) · ResearchSpace (University of KwaZulu-Natal)
Mohammad Darvishi, M. N., Nouri, M., Rahimi, F., & Abadi, A. T. B. (2025) · Pegem Journal of Education and Instruction
Rampershad, K., Msibi, Z. N. P., & Enicker, B. (2026) · BMJ Paediatrics Open · doi:10.1136/bmjpo-2025-004408
Metadata
- Authors
- Oliveira, C. F., Botoni, F. A., Oliveira, C. R. A., Silva, C. B., Pereira, H. A., Serufo, J. C., & Nobre, V.
- Affiliations
- Universidade Federal de Minas Gerais (BR)
- Venue
- Critical Care Medicine
- Published
- 2013-10
- Volume
- 41
- Issue
- 10
- Pages
- 2336-2343
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2079018559
- Semantic Scholar
- 3891d0cdee5f3e4ad39527256fb686aa6935d02c
- Cited by
- 213
- References
- 38
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 24 · 2023: 14 · 2022: 19 · 2021: 13 · 2020: 25 · 2019: 14 · 2018: 23 · 2017: 19 · 2016: 14 · 2015: 10 · 2014: 14 · 2013: 1
- FWCI
- 9.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Universidade Federal de Minas Gerais
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- procalcitonin, C-reactive protein, sepsis, septic shock, antibiotic stewardship, antibiotic duration, biomarkers, intensive care unit patients, bacteremia
- MeSH terms
- Aged, Anti-Bacterial Agents, Brazil, C-Reactive Protein, Calcitonin, Female, Hospitals, University, Humans, Intensive Care Units, Male, Middle Aged, Protein Precursors, Shock, Septic, Biomarkers, Calcitonin Gene-Related Peptide, Confidence Intervals, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.